Utility and safety of procalcitonin in an antimicrobial stewardship program (ASP) in patients with malignancies

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 31, Issue 11, 2012, Pages 3041-3046

  Liew, Y X ^a   Lee, W ^a   Cai, Y Y ^a   Teo, J ^a   Tang, S S L ^a   Ong, R W Q ^a   Lim, C L L ^a   Lingegowda, P B ^a   Kwa, A L H ^a   Chlebicki, M P ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEM; CEFEPIME; ERTAPENEM; IMIPENEM; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; PROCALCITONIN;

ADULT; AGGRESSIVE NK CELL LEUKEMIA; ANTIMICROBIAL STEWARDSHIP PROGRAM; ARTICLE; CAUSE OF DEATH; CONTROLLED STUDY; DRUG DOSE ESCALATION; DRUG USE; DRUG WITHDRAWAL; FEBRILE NEUTROPENIA; FEMALE; HEALTH PROGRAM; HORMONE DETERMINATION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MEDICAL DECISION MAKING; METASTASIS; MORTALITY; OUTCOME ASSESSMENT; PALLIATIVE THERAPY; PNEUMONIA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SOLID TUMOR; SURVIVAL RATE; TREATMENT DURATION; TREATMENT WITHDRAWAL;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; BIOLOGICAL MARKERS; CALCITONIN; CARBAPENEMS; DRUG MONITORING; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PROTEIN PRECURSORS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84867994885     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-012-1662-2     Document Type: Article

References (11)

1. Lipsitch M, Bergstrom CT, Levin BR (2000) The epidemiology of antibiotic resistance in hospitals: paradoxes and prescriptions. Proc Natl Acad Sci USA 97(4):1938-1943
2. Gould CV, Rothenberg R, Steinberg JP (2006) Antibiotic resistance in long-term acute care hospitals: the perfect storm. Infect Control Hosp Epidemiol 27(9):920-925
3. McGowan JE Jr (1983) Antimicrobial resistance in hospital organisms and its relation to antibiotic use. Rev Infect Dis 5(6):1033-1048
4. Hsu L-Y, Tan T-Y, Tam VH, Kwa A, Fisher DA, Koh T-H; Network for Antimicrobial Resistance Surveillance (Singapore) (2010) Surveillance and correlation of antibiotic prescription and resistance of Gram-negative bacteria in Singaporean hospitals. Antimicrob Agents Chemother 54(3):1173-1178
5. Liew YX, Chlebicki MP, Lee W, Hsu LY, Kwa AL (2011) Use of procalcitonin (PCT) to guide discontinuation of antibiotic use in an unspecified sepsis is an antimicrobial stewardship program (ASP). Eur J Clin Microbiol Infect Dis 30(7):853-855
6. McGregor JC, Kim PW, Perencevich EN, Bradham DD, Furuno JP, Kaye KS, Fink JC, Langenberg P, Roghmann M-C, Harris AD (2005) Utility of the Chronic Disease Score and Charlson Comorbidity Index as comorbidity measures for use in epidemiologic studies of antibiotic-resistant organisms. Am J Epidemiol 161(5):483-493
7. Rhee J-Y, Kwon KT, Ki HK, Shin SY, Jung DS, Chung D-R, Ha B-C, Peck KR, Song J-H (2009) Scoring systems for prediction of mortality in patients with intensive care unit-acquired sepsis: a comparison of the Pitt bacteremia score and the Acute Physiology and Chronic Health Evaluation II scoring systems. Shock 31(2):146-150
8. Seto WH, Ching TY, Kou M, Chiang SC, Lauder IJ, Kumana CR (1996) Hospital antibiotic prescribing successfully modified by 'immediate concurrent feedback'. Br J Clin Pharmacol 41(3):229-234
9. Liew YX, Lee W, Kwa AL, Lye DC, Yeo CL, Hsu LY (2011) Inappropriate carbapenem use in Singapore public hospitals: opportunities for antimicrobial stewardship. Int J Antimicrob Agents 37(1):87-88
10. Sandri MT, Passerini R, Leon ME, Peccatori FA, Zorzino L, Salvatici M, Riggio D, Cassatella C, Cinieri S, Martinelli G (2008) Procalcitonin as a useful marker of infection in hemato-oncological patients with fever. Anticancer Res 28(5B):3061-3065
11. Schüttrumpf S, Binder L, Hagemann T, Berkovic D, Trümper L, Binder C (2003) Procalcitonin: a useful discriminator between febrile conditions of different origin in hemato-oncological patients? Ann Hematol 82(2):98-103